Alkem Laboratories Limited (NSE:ALKEM)
4,902.50
+3.50 (0.07%)
Aug 4, 2025, 3:30 PM IST
Iteris Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
129,645 | 126,676 | 115,993 | 106,342 | 88,650 | Upgrade | |
Revenue Growth (YoY) | 2.34% | 9.21% | 9.07% | 19.96% | 6.24% | Upgrade |
Cost of Revenue | 49,255 | 50,642 | 50,207 | 42,806 | 35,751 | Upgrade |
Gross Profit | 80,391 | 76,034 | 65,785 | 63,536 | 52,899 | Upgrade |
Selling, General & Admin | 32,422 | 30,324 | 29,726 | 25,769 | 19,807 | Upgrade |
Other Operating Expenses | 22,879 | 23,041 | 19,760 | 17,305 | 13,617 | Upgrade |
Operating Expenses | 58,873 | 56,359 | 52,589 | 46,103 | 36,160 | Upgrade |
Operating Income | 21,518 | 19,676 | 13,196 | 17,432 | 16,739 | Upgrade |
Interest Expense | -1,048 | -970.8 | -809.2 | -308.9 | -398.7 | Upgrade |
Interest & Investment Income | 3,588 | 2,758 | 1,711 | 1,227 | 901.2 | Upgrade |
Earnings From Equity Investments | -6.2 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 380 | -335.1 | -188.6 | -16.5 | 458.4 | Upgrade |
Other Non Operating Income (Expenses) | 239.6 | 179.2 | -12.8 | -24.2 | -36.7 | Upgrade |
EBT Excluding Unusual Items | 24,671 | 21,307 | 13,897 | 18,309 | 17,664 | Upgrade |
Gain (Loss) on Sale of Investments | 528.9 | 151.7 | 308.6 | 114.5 | 369.5 | Upgrade |
Gain (Loss) on Sale of Assets | 46 | -31.8 | -123.6 | 19.7 | 388 | Upgrade |
Asset Writedown | -137.3 | -576.5 | -1,051 | -11.2 | - | Upgrade |
Other Unusual Items | 155.1 | -618.6 | 17.4 | 10.5 | - | Upgrade |
Pretax Income | 25,264 | 20,231 | 13,048 | 18,443 | 18,421 | Upgrade |
Income Tax Expense | 3,110 | 2,117 | 2,980 | 1,640 | 2,243 | Upgrade |
Earnings From Continuing Operations | 22,154 | 18,115 | 10,068 | 16,803 | 16,178 | Upgrade |
Minority Interest in Earnings | -499 | -156.9 | -226.4 | -347 | -327.5 | Upgrade |
Net Income | 21,655 | 17,958 | 9,842 | 16,456 | 15,850 | Upgrade |
Net Income to Common | 21,655 | 17,958 | 9,842 | 16,456 | 15,850 | Upgrade |
Net Income Growth | 20.59% | 82.47% | -40.20% | 3.82% | 40.63% | Upgrade |
Shares Outstanding (Basic) | 120 | 120 | 120 | 120 | 120 | Upgrade |
Shares Outstanding (Diluted) | 120 | 120 | 120 | 120 | 120 | Upgrade |
EPS (Basic) | 181.11 | 150.19 | 82.31 | 137.63 | 132.57 | Upgrade |
EPS (Diluted) | 181.11 | 150.19 | 82.31 | 137.63 | 132.57 | Upgrade |
EPS Growth | 20.59% | 82.47% | -40.20% | 3.82% | 40.63% | Upgrade |
Free Cash Flow | 12,372 | 16,888 | 14,496 | 7,721 | 10,700 | Upgrade |
Free Cash Flow Per Share | 103.48 | 141.24 | 121.24 | 64.58 | 89.49 | Upgrade |
Dividend Per Share | 45.000 | 40.000 | 25.000 | 34.000 | 30.000 | Upgrade |
Dividend Growth | 12.50% | 60.00% | -26.47% | 13.33% | 20.00% | Upgrade |
Gross Margin | 62.01% | 60.02% | 56.72% | 59.75% | 59.67% | Upgrade |
Operating Margin | 16.60% | 15.53% | 11.38% | 16.39% | 18.88% | Upgrade |
Profit Margin | 16.70% | 14.18% | 8.48% | 15.47% | 17.88% | Upgrade |
Free Cash Flow Margin | 9.54% | 13.33% | 12.50% | 7.26% | 12.07% | Upgrade |
EBITDA | 24,619 | 22,268 | 15,893 | 20,122 | 19,147 | Upgrade |
EBITDA Margin | 18.99% | 17.58% | 13.70% | 18.92% | 21.60% | Upgrade |
D&A For EBITDA | 3,101 | 2,592 | 2,697 | 2,690 | 2,408 | Upgrade |
EBIT | 21,518 | 19,676 | 13,196 | 17,432 | 16,739 | Upgrade |
EBIT Margin | 16.60% | 15.53% | 11.38% | 16.39% | 18.88% | Upgrade |
Effective Tax Rate | 12.31% | 10.46% | 22.84% | 8.89% | 12.18% | Upgrade |
Revenue as Reported | 134,583 | 129,784 | 118,153 | 107,968 | 90,982 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.